Knobbe, Martens, Olson & Bear, LLP
Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte binding proteins
 The present invention provides isolated polypeptides useful in the treatment and prevention of malaria caused by Plasmodium falciparum or P. vivax. In particular, the polypeptides are derived from the binding domains of the proteins in the EBL family as well as the sialic acid binding protein (SABP) on P. falciparum merozoites. The polypeptides may also be derived from the Duffy antigen binding protein (DABP) on P. vivax merozoites. 
The United States of America as represented by the Department of Health and Human Services
Y A A A C
Y02A A61P A61P A61K C07K
additional inventional inventional additional inventional
Kim Lee Xin-Zhuan Louis H. Chetan David S. Thomas E.
Sim Su Miller Chitnis Peterson Wellems